Sars-Cov2 Envelope Proteine Mybiosource

Human anti-SARS-CoV2(N) IgG ELISA Kit
EKF60809-48T 48T
EUR 400.4

Human IgG antibody Laboratories manufactures the sars-cov2 envelope proteine mybiosource reagents distributed by Genprice. The Sars-Cov2 Envelope Proteine Mybiosource reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Mybiosource. Other Sars-Cov2 products are available in stock. Specificity: Sars-Cov2 Category: Envelope Group: Proteine Mybiosource

Human anti-SARS-CoV2(S) IgG ELISA Kit
96T
EUR 572

Human anti-SARS-CoV2 (S) IgG ELISA Kit
10x96-Strip-Wells
EUR 3900

Human anti-SARS-CoV2 (S) IgG ELISA Kit
48-Strip-Wells
EUR 340

Human anti-SARS-CoV2 (S) IgG ELISA Kit
5x96-Strip-Wells
EUR 2045

Human anti-SARS-CoV2 (S) IgG ELISA Kit
96-Strip-Wells
EUR 455

Human anti-SARS-CoV2 IgG ELISA Kit (quantitative)
10x96-Strip-Wells
EUR 3900

Human anti-SARS-CoV2 IgG ELISA Kit (quantitative)
48-Strip-Wells
EUR 340

Human anti-SARS-CoV2 IgG ELISA Kit (quantitative)
5x96-Strip-Wells
EUR 2045

Human anti-SARS-CoV2 IgG ELISA Kit (quantitative)
96-Strip-Wells
EUR 455

Human anti-SARS-CoV2 (S1 protein) IgG ELISA Kit
10x96-Strip-Wells
EUR 3900

Human anti-SARS-CoV2 (S1 protein) IgG ELISA Kit
48-Strip-Wells
EUR 340

Human anti-SARS-CoV2 (S1 protein) IgG ELISA Kit
5x96-Strip-Wells
EUR 2045

Proteine Mybiosource information

SARS-CoV-2 (COVID-19) Envelope Antibody (HRP)
MBS154812-01mg 0.1mg
EUR 500

SARS-CoV-2 (COVID-19) Envelope Antibody (HRP)
MBS154812-5x01mg 5x0.1mg
EUR 2230

SARS-CoV-2 envelope protein Antibody
MBS5401506-01mg 0.1mg
EUR 445

SARS-CoV-2 envelope protein Antibody
MBS5401506-5x01mg 5x0.1mg
EUR 1855

SARS-CoV-2 (COVID-19) Envelope antibody (biotin)
MBS154772-01mg 0.1mg
EUR 500

SARS-CoV-2 (COVID-19) Envelope antibody (biotin)
MBS154772-5x01mg 5x0.1mg
EUR 2230

Envelope Protein (E) of SARS-CoV-2
MBS430577-005mg 0.05mg
EUR 325

Envelope Protein (E) of SARS-CoV-2
MBS430577-5x005mg 5x0.05mg
EUR 1305

Recombinant SARS-CoV-2 Envelope Protein
MBS669452-01mg 0.1mg
EUR 650

Recombinant SARS-CoV-2 Envelope Protein
MBS669452-5x01mg 5x0.1mg
EUR 2805

SARS-CoV-2 Envelope Protein
abx620055-100g 100 µg
EUR 250

SARS-CoV-2 Envelope Protein
abx620055-1mg 1 mg
EUR 1362.5

SARS-CoV-2 Envelope Protein
abx620055-200g 200 µg
EUR 350

SARS-CoV-2 Envelope Protein
abx163976-100g 100 µg Ask for price

SARS-CoV-2 Envelope Protein
abx163976-10g 10 µg
EUR 262.5

SARS-CoV-2 Envelope Protein
abx163976-50g 50 µg
EUR 887.5

SARS Envelope Protein Polyclonal Antibody
MBS191604-01mL 0.1mL
EUR 370

SARS Envelope Protein Polyclonal Antibody
MBS191604-5x01mL 5x0.1mL
EUR 1650

SARS Envelope Protein Polyclonal Antibody
MBS191605-01mL 0.1mL
EUR 370

SARS Envelope Protein Polyclonal Antibody
MBS191605-5x01mL 5x0.1mL
EUR 1650

SARS-CoV-2 (COVID-19) Envelope Peptide
9169P 0.05 mg
EUR 235.5
Description: SARS-CoV-2 (COVID-19) Envelope Peptide

SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody
MBS150849-01mg 0.1mg
EUR 445

SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody
MBS150849-5x01mg 5x0.1mg
EUR 1965

SARS-CoV-2 (COVID-19) Envelope Antibody
9169-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic corona virus E proteins, and also viral replication (3).

SARS-CoV-2 (COVID-19) Envelope Antibody
9169-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The envelope protein is a small polypeptide that contains at least one α-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic corona virus E proteins, and also viral replication (3).

SARS-CoV-2 (COVID-19) Envelope Antibody
3531-002mg 0.02 mg
EUR 206.18
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Envelope protein is a small polypeptide that contains at least one alpha-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication (3).

SARS-CoV-2 (COVID-19) Envelope Antibody
3531-01mg 0.1 mg
EUR 523.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Envelope protein is a small polypeptide that contains at least one alpha-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication (3).

Recombinant SARS Envelope Protein
SARS-394 1 vial
EUR 798.4
Description: Protein